GW406108X (b)

CAS No. 265098-01-9

GW406108X (b)( —— )

Catalog No. M24176 CAS No. 265098-01-9

GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 282 In Stock
5MG 287 In Stock
10MG 430 In Stock
25MG 646 In Stock
50MG 949 In Stock
100MG 1274 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GW406108X (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .
  • Description
    GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    Kinesin-12| ULK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    265098-01-9
  • Formula Weight
    400.21
  • Molecular Formula
    C20H11Cl2NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC2=C(C=C(C(C3=CC=CO3)=O)C=C2)C1=CC4=CC(Cl)=C(O)C(Cl)=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dumas M E , Chen G Y , Kendrick N D , et al. Dual inhibition of Kif15 by oxindole and quinazolinedione chemical probes[J]. Bioorganic & Medicinal Chemistry Letters, 2018, 29(2).
molnova catalog
related products
  • Metformin-d6 hydroch...

    Metformin-d6 hydrochloride (Metformin-d6 hydrochloride) is a deuterated form of Metformin that can be used to study Metformin metabolism in vivo, and is often used as an internal standard for Metformin.

  • Talarozole

    Talarozole is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM respectively.Talarozole for the treatment of acne psoriasis and other keratinization disorders.

  • Succinylsulfathiazol...

    Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.